Recombinant human migration inhibitory factor has adjuvant activity.

AUTOR(ES)

Weiser, W Y

RESUMO

Recombinant human migration inhibitory factor (MIF), isolated through functional expression cloning in COS-1 cells, up-regulates expression of genes encoding HLA-DR and interleukin 1 beta (IL-1 beta) and elaboration of IL-1 beta by human monocyte-derived macrophages. Administration of soluble bovine serum albumin or human immunodeficiency virus 120-kDa glycoprotein (HIV gp120) to mice in the presence of recombinant MIF together with incomplete Freund's adjuvant induced a strong T-cell proliferative response comparable to that of complete Freund's adjuvant. Recombinant MIF also increased antibody production, especially of IgG1 and IgM, in mice. Taken together, these results indicate that recombinant MIF may be useful as an adjuvant in the development of vaccines.

Documentos Relacionados

• Macrophage migration inhibitory activity of mycobacterial growth inhibitory factor and the effect of a number of factors on mycobacterial growth inhibitory factor activity.
• Purified human platelet-derived growth factor receptor has ligand-stimulated tyrosine kinase activity.
• A glia-derived neurite-promoting factor with protease inhibitory activity.
• Recombinant human epidermal growth factor precursor is a glycosylated membrane protein with biological activity.
• Purification of a lymphoid cell line product with leukocyte inhibitory factor activity.